You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Heart failure, reduced ejection fraction, LCZ696, titration, safety, tolerability

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Heart Failure Trial in Houston (JTT-861 Capsules, Placebo Capsules)

Recruiting
  • Chronic Heart Failure
  • JTT-861 Capsules
  • Placebo Capsules
  • Houston, Texas
    East Texas Cardiology PA
Aug 24, 2023

Heart Failure, Electric Impedance, Dyspnea Trial in Córdoba (Diuretics withdrawal, Diuretics maintenance)

Recruiting
  • Heart Failure
  • +4 more
  • Diuretics withdrawal
  • Diuretics maintenance
  • Córdoba, Córdoba (Andalucía), Spain
    Hospital Universitario Reina Sofía
Jul 25, 2023

Finerenone in Heart Failure With Reduced Ejection Fraction

Not yet recruiting
  • Heart Failure With Reduced Ejection Fraction
  • +2 more
    • (no location specified)
    Jul 26, 2023

    Heart Failure With Preserved Ejection Fraction Trial (CDR132L, Placebo)

    Not yet recruiting
    • Heart Failure With Preserved Ejection Fraction
    • (no location specified)
    Jul 18, 2023

    Heart Failure With Reduced Ejection Fraction (HFrEF) Trial in Jacksonville, Saint Paul (XXB750, Placebo)

    Recruiting
    • Heart Failure With Reduced Ejection Fraction (HFrEF)
    • Jacksonville, Florida
    • +2 more
    Jan 13, 2023

    Heart Failure With Reduced Ejection Fraction Trial in Durham (Digital Heart Failure Medication Titration)

    Recruiting
    • Heart Failure With Reduced Ejection Fraction
    • Digital Heart Failure Medication Titration
    • Durham, North Carolina
      Duke University
    Dec 5, 2022

    Heart Failure With Reduced Ejection Fraction Trial (AC01)

    Not yet recruiting
    • Heart Failure With Reduced Ejection Fraction
    • (no location specified)
    Jan 31, 2023

    Chronic Heart Failure With Reduced Ejection Fraction Trial in Shenzhen (To evaluate whether the efficacy of the study drug is

    Recruiting
    • Chronic Heart Failure With Reduced Ejection Fraction
    • To evaluate whether the efficacy of the study drug is noninferior to that of the positive control drug
    • Shenzhen, Guangdong, China
      Shenzhen People' S Hospital
    Oct 31, 2022

    Heart Failure With Reduced Ejection Fraction Trial in United States (JK07, Matching Placebo)

    Active, not recruiting
    • Heart Failure With Reduced Ejection Fraction
    • Tucson, Arizona
    • +6 more
    Jan 30, 2023

    Heart Failure Trial (Finerenone, Placebo)

    Not yet recruiting
    • Heart Failure
    • (no location specified)
    Sep 11, 2023

    Heart Failure, Systolic Trial in Karachi (Sacubitril/valsartan)

    Completed
    • Heart Failure, Systolic
    • Karachi, Sindh, Pakistan
      National Institute of Cardiovascular Diseases
    May 20, 2022

    Heart Failure, Heart Failure With Reduced Ejection Fraction, Implantable Defibrillator User Trial (OPTIMIZER® Integra CCM-D

    Not yet recruiting
    • Heart Failure
    • +9 more
    • OPTIMIZER® Integra CCM-D System (Treatment Arm)
    • (no location specified)
    May 3, 2023

    Heart Failure Trial in Chi?inau (REGN5381, Placebo)

    Recruiting
    • Heart Failure
    • Chișinău, Moldova, Republic of
      ARENSIA Exploratory Medicine at the Republican Clinical Hospital
    Aug 3, 2022

    Congenital Heart Disease, Heart Failure, Heart Failure With Reduced Ejection Fraction Trial in Mexico City (Sacubitril 49 MG /

    Not yet recruiting
    • Congenital Heart Disease
    • +2 more
    • Sacubitril 49 MG / Valsartan 51 MG [Entresto] BID
    • Empagliflozin 10 MG OD
    • Mexico City, Mexico
      National Institute of Cardiology Ignacio Chavez
    Oct 31, 2022

    Chronic Heart Failure With Reduced Ejection Fraction, Worsening Heart Failure Trial in Vadodara, Nashik (Vericiguat (Verquvo,

    Recruiting
    • Chronic Heart Failure With Reduced Ejection Fraction
    • Worsening Heart Failure
    • Vericiguat (Verquvo, BAY1021189)
    • Vadodara, Gujarat, India
    • +1 more
    Jan 16, 2023

    Heart Failure With Reduced Ejection Fraction HFrEF Trial in Sukoharjo (Carvedilol)

    Recruiting
    • Heart Failure With Reduced Ejection Fraction HFrEF
    • Sukoharjo, Central Of Java, Indonesia
      Universitas Sebelas Maret Hospital
    Dec 20, 2021

    Type 2 Diabetes Trial (SGLT2 inhibitor)

    Not yet recruiting
    • Type 2 Diabetes Mellitus
    • SGLT2 inhibitor
    • (no location specified)
    Feb 12, 2023

    Heart Failure With Reduced Ejection Fraction, HIV Trial in San Francisco (Heart failure polypill, Control Rx)

    Not yet recruiting
    • Heart Failure With Reduced Ejection Fraction
    • HIV Infections
    • Heart failure polypill
    • Control Rx
    • San Francisco, California
      Zuckerberg San Francisco General Hospital
    Sep 1, 2023

    Chronic Heart Failure With Reduced Ejection Fraction Trial in Germany (LCZ696, Enalapril, Placebo matching enalapril)

    Completed
    Has Results
    • Chronic Heart Failure With Reduced Ejection Fraction
    • Regensburg, Bavaria, Germany
    • +33 more
    Oct 7, 2021

    Acute Heart Failure With Reduced Ejection Fraction Trial in Worldwide (APD418, Placebo)

    Terminated
    • Acute Heart Failure With Reduced Ejection Fraction
    • Tampa, Florida
    • +20 more
    Sep 20, 2022

    Called VERI-China, to Learn More About How Well Vericiguat Works

    Not yet recruiting
    • Chronic Heart Failure With Reduced Ejection Fraction
    • Vericiguat (Verquvo, BAY1021189)
    • Standard of Care (SoC)
    • Multiple Locations, Many Locations, China
      Chinese Registries
    Feb 6, 2023

    Heart Failure With Preserved Ejection Fraction (HFpEF) Trial in Japan (LCZ696)

    Terminated
    Has Results
    • Heart Failure With Preserved Ejection Fraction (HFpEF)
    • Seto-city, Aichi, Japan
    • +16 more
    Oct 7, 2021

    CHF, Heart Failure, Systolic, Heart Failure Trial in San Diego (SRD-001, Placebo)

    Recruiting
    • Congestive Heart Failure
    • +2 more
    • SRD-001
    • Placebo
    • San Diego, California
      San Diego Cardiac Center
    Jul 26, 2022

    Heart Failure, Essential Hypertension Trial in Moscow (LCZ 696, Valsartan)

    Recruiting
    • Heart Failure
    • Essential Hypertension
    • Moscow, Russian Federation
      National Medical Research Center for Cardiology
    Jan 10, 2022

    Heart Failure Trial in Tbilisi (ALV1 System)

    Completed
    • Heart Failure
    • ALV1 System
    • Tbilisi, Georgia
      Tbilisi Heart & Vascular
    Jul 26, 2022